3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Psychotic Disorders
1
Lymphoma, Follicular
1
Head and Neck Neoplasms
1
Glioblastoma
1
Epilepsy
1
Bipolar Disorder
1
Interventions
Sirolimus
2
Temozolomide
1
Sulfasalazine
1
Radiotherapy
1
Memantine
1
Medical Marijuana
1
Magnetoencephalography
1
Gabapentin
1
Clinical Laboratory Techniques
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Epilepsy
×
Gabapentin
×
Clear all
NCT05664464
2024-05-10
GLUGLIO
University of Zurich
Phase 1/2
Recruiting
120 enrolled